February 23, 2024Open Access

Outcomes of intravitreal anti-VEGF injections and panretinal photocoagulation in preretinal hemorrhage secondary to proliferative diabetic retinopathy involving the fovea

Key Points

Key points are not available for this paper at this time.

Abstract

To evaluate the outcome of intravitreal anti-vascular endothelial growth factor (VEGF) injections and panretinal photocoagulation (PRP) in fovea involving preretinal hemorrhage (PRH) secondary to proliferative diabetic retinopathy (PDR).

Read Full Paperexternally

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Brar et al. (Fri,) studied this question.

synapsesocial.com/papers/68e77f43b6db6435876f2899 https://doi.org/https://doi.org/10.4103/ijo.ijo_2296_23

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Intravitreal Anti-Vascular Endothelial Growth Factor for Submacular Hemorrhage from Choroidal Neovascularization2013 · 90 citations
2Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 241999 · 205 citations
3Diabetic Dense Premacular Hemorrhage1985 · 110 citations
4Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial2017 · 387 citations
5Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy1994 · 1,297 citations

Perguntar à IA

Bookmark

View Full Paper